Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BDNF Antikörper (Middle Region)

BDNF Reaktivität: Human, Ratte, Maus, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN548503
  • Target Alle BDNF Antikörper anzeigen
    BDNF (Brain-Derived Neurotrophic Factor (BDNF))
    Bindungsspezifität
    • 16
    • 16
    • 11
    • 10
    • 8
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reaktivität
    • 116
    • 58
    • 56
    • 14
    • 10
    • 10
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 1
    Human, Ratte, Maus, Kaninchen
    Wirt
    • 112
    • 24
    • 4
    • 3
    • 2
    • 2
    Kaninchen
    Klonalität
    • 116
    • 30
    Polyklonal
    Konjugat
    • 84
    • 17
    • 10
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BDNF Antikörper ist unkonjugiert
    Applikation
    • 115
    • 48
    • 47
    • 31
    • 25
    • 25
    • 18
    • 13
    • 13
    • 12
    • 9
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of BDNF.
    Spezifität
    Identical to the related rat and mouse sequence.
    Kreuzreaktivität
    Human, Maus, Kaninchen, Ratte
    Immunogen
    A synthetic peptide corresponding to amino acids at middle region of human BDNF.
    Isotyp
    IgG
    Top Product
    Discover our top product BDNF Primärantikörper
  • Applikationshinweise
    Western Blot (1-2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Buffer
    Lyophilized from 0.9 mg NaCl, 0.2 mg Na2HPO4 (5 mg BSA, 0.05 mg sodium azide, 0.05 mg Thimerosal)
    Konservierungsmittel
    Sodium azide, Thimerosal (Merthiolate)
    Vorsichtsmaßnahmen
    This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C on dry atmosphere.
    After reconstitution with 200 uL of deionized water and concentration will be 500 ug/mL, store at -20°C or lower.
    Aliquot to avoid repeated freezing and thawing.
  • Pruunsild, Kazantseva, Aid, Palm, Timmusk: "Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters." in: Genomics, Vol. 90, Issue 3, pp. 397-406, (2007) (PubMed).

    Lee, Kermani, Teng, Hempstead: "Regulation of cell survival by secreted proneurotrophins." in: Science (New York, N.Y.), Vol. 294, Issue 5548, pp. 1945-8, (2001) (PubMed).

  • Target
    BDNF (Brain-Derived Neurotrophic Factor (BDNF))
    Andere Bezeichnung
    BDNF (BDNF Produkte)
    Synonyme
    ANON2 antikoerper, BULN2 antikoerper, bdnf-A antikoerper, BDNF antikoerper, bdnf antikoerper, brain derived neurotrophic factor antikoerper, brain-derived neurotrophic factor antikoerper, brain-derived neurotrophic factor L homeolog antikoerper, brain-derived neurotrophic factor S homeolog antikoerper, BDNF antikoerper, Bdnf antikoerper, bdnf antikoerper, bdnf.L antikoerper, bdnf.S antikoerper
    Gen-ID
    627
    Pathways
    RTK Signalweg, Synaptic Membrane, Feeding Behaviour, Dicarboxylic Acid Transport, Regulation of long-term Neuronal Synaptic Plasticity
Sie sind hier:
Kundenservice